MDXG Q3 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$114M+35.3% YoY

Gross Profit

$95M83.5% margin

Operating Income

$22M19.5% margin

Net Income

$17M14.7% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+15.3%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$25M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$319M

Total Liabilities

$80M

Stockholders' Equity

$239M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$114M	$84M	+35.3%
Gross Profit	$95M	$69M	+38.2%
Operating Income	$22M	$11M	+98.8%
Net Income	$17M	$8M	+106.9%

Revenue Segments

Surgical

$37M100%